SCHEDULE 13G: Polar Capital Discloses 9.13% Stake in NeuroPace Inc.
Beneficial Ownership Report
Polar Capital Holdings Plc and Polar Capital LLP have jointly disclosed a beneficial ownership of 9.13% in NeuroPace Inc., holding 2,972,003 shares of common stock.
Summary
- Polar Capital Holdings Plc and Polar Capital LLP have filed a Schedule 13G, reporting their beneficial ownership in NeuroPace Inc.
- As of March 31, 2025, the reporting persons collectively beneficially own 2,972,003 shares of NeuroPace Inc.'s common stock.
- This ownership represents 9.13% of NeuroPace Inc.'s outstanding common stock.
- The percentage is calculated based on 32,560,130 shares outstanding, as reported in NeuroPace Inc.'s Form 10-K on March 4, 2025.
- Both Polar Capital Holdings Plc and Polar Capital LLP hold sole voting and sole dispositive power over all 2,972,003 shares.
- Polar Capital Holdings Plc is classified as a Holding Company (HC), and Polar Capital LLP is classified as an Investment Adviser (IA).
Sentiment
Score: 7
Explanation: The disclosure of a significant 9.13% stake by an established investment firm like Polar Capital Holdings Plc and Polar Capital LLP is generally viewed positively by the market, indicating institutional confidence in NeuroPace Inc.
Positives
- Polar Capital Holdings Plc and Polar Capital LLP, a UK-based investment firm, have taken a significant 9.13% stake in NeuroPace Inc., indicating potential confidence in the company's future.
Future Outlook
NA
Industry Context
NeuroPace Inc. operates in the healthcare or medical device sector, and this filing indicates a significant institutional investor's interest in the company, suggesting potential confidence in its market position or future prospects within the industry.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake may instill confidence and potentially influence stock price positively.
Key Dates
| Date | Description |
|---|---|
| 2025-03-04 | Date NeuroPace Inc.'s Form 10-K reported 32,560,130 shares outstanding. |
| 2025-03-31 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 2025-05-15 | Date of filing of the Schedule 13G. |
Keywords
NeuroPace Inc, Polar Capital, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investment, equity stake, medical device company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.